SCHEMBL12412709

SCHEMBL12412709

CC(C)(C)c1ccc(CN2CCC(O)CC2)cc1

nearest known ligand 0.63

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.59
KDM4E B2RXH2 1/20 0.59
GAA P10253 1/20 0.59
MEN1 O00255 3/20 0.56
KMT2A Q03164 3/20 0.56
RAB9A P51151 2/20 0.56
CYP2D6 P10635 1/20 0.56
TEAD1 P28347 2/20 0.53
NPC1 O15118 1/20 0.51
SIGMAR1 Q99720 3/20 0.50
HRH3 Q9Y5N1 3/20 0.50
DRD2 P14416 1/20 0.50
HTR2A P28223 1/20 0.50
HTR2C P28335 1/20 0.50
HTR2B P41595 1/20 0.50
KCNH2 Q12809 1/20 0.49
ACHE P22303 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12449569 0.90 ALDH1A1 (0.53) ALDH1A1KDM4EGAAMEN1KMT2A
SCHEMBL12891076 0.90 ALDH1A1 (0.53) ALDH1A1KDM4EGAAMEN1KMT2A
SCHEMBL12449549 0.85 TEAD1 (0.58) ALDH1A1KDM4EMEN1KMT2ATEAD1
SCHEMBL798027 0.85 HRH3 (0.69) MEN1KMT2ATEAD1SIGMAR1HRH3
SCHEMBL12412713 0.84 HRH3 (0.52) MEN1KMT2ATEAD1SIGMAR1HRH3
SCHEMBL1044315 0.84 KCNH2 (0.58) ALDH1A1KDM4EMEN1KMT2ARAB9A
SCHEMBL13602641 0.83 TEAD1 (0.53) MEN1KMT2ATEAD1SIGMAR1HRH3
SCHEMBL1035980 0.83 ALDH1A1 (0.65) ALDH1A1KDM4EMEN1KMT2ARAB9A
SCHEMBL9139565 0.83 TEAD1 (0.53) ALDH1A1KDM4EMEN1KMT2ARAB9A
SCHEMBL15942967 0.83 S1PR1 (0.51) ALDH1A1KDM4EMEN1KMT2ARAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8802663-B2 Pyrazole oxadiazole derivatives as S1P1 agonists MERCK SERONO SA (CH) 2014-08-12 US disclosed
CN-102153544-A Preparation method and application of novel tyrosine kinase inhibitors SHANGHAI SUN SAIL PHARMACEUTICAL SCIENCE & TECHNOLOGY CO LTD 2011-08-17 CN disclosed
US-20110166088-A1 BENZOTHIAZOLES AND AZA-ANALOGUES THEREOF USE AS ANTIBACTERIAL AGENTS RANBAXY LABORATORIES LIMITED (IN) 2011-07-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110166088-A1 BENZOTHIAZOLES AND AZA-ANALOGUES THEREOF USE AS ANTIBACTERIAL AGENTS TOP2B, TOP1, POLI ALDH1A1 2009/4885KDM4E 315/4885GAA 100/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.